NCT05580822View on ClinicalTrials.gov

Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Basilar Artery OcclusionThrombectomyTenecteplase
Interventions
DRUG

Tenecteplase for Injection

intra-arterial TNK infusing after successful thrombectomy for patient with acute basilar artery occlusion via support/access catheter

DRUG

Saline

intra-arterial saline infusing after successful thrombectomy for patient with acute basilar artery occlusion via support/access catheter

All Listed Sponsors
lead

First Hospital of China Medical University

OTHER

NCT05580822 - Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion | Biotech Hunter | Biotech Hunter